Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
For full access to this article login to GEN Select now.
Supplement: Best of CRISPR 2017
Peak CRISPR: On the Cusp of a Biomedical Revolution
- One sweltering summer afternoon in 2003, a vacationing Spanish microbiologist named Francisco Mojica told his wife he was going to seek refuge in his air-conditioned lab at the University of Alicante. For years, Mojica had been puzzling over the putative function of a bizarre stretch of DNA that had ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.